A doctor discusses the most common issues and questions Americans may have with the FDA's approval of the new oral obesity pill Foundayo
Loading story…
Loading story…
A doctor discusses the most common issues and questions Americans may have with the FDA's approval of the new oral obesity pill Foundayo

A doctor discusses the most common issues and questions Americans may have with the FDA's approval of the new oral obesity pill Foundayo
Same desk, different stories
The less “antagonistic” tone of TBPN resonated with a Silicon Valley audience. Now the show is going mainstream.

AI agents just powered personalized networking for 6,000 HumanX attendees. The results, the risks, and three lessons every AI leader should take from this deployment.

We often assume that being selfish will cost us relationally. However, it may cost us far less than having no boundaries at all.

‘Project Walleye’ lenders would be first to fund both construction and power

Men are driving the next wave of medspa growth - from Botox to body contouring - as private equity races to consolidate a fragmented, $78 billion global market. Find out which funds are betting on male aesthetics and…

This week’s Apple headlines: fifty years of Apple, urgent iOS updates, iPhone 18 design leaks, MacBook Pro discounts, Product Red leaves the Apple Store and more...